News
State of the Art 2023: webcasts available
The first State of the Art 2023: ESDR and UADV webcasts are now available on the ESDR website with...
ESDR Board meeting 2023.10
The ESDR Board met in Berlin, Germany last Saturday. Sabine Eming, as the President for the...
ESDR 2024 confirmed speakers
Join us in Lisbon, Portugal from 4 to 7 September 2024 for 4 days of scientific excellence,...
DEPARTURE OF ESDR BOARD MEMBERS 2023
The European Society for Dermatological Research (ESDR) held its AGM on 12 May 2023 during the...
NEW MEMBERS ELECTED TO ESDR BOARD 2024
The European Society for Dermatological Research (ESDR) held its AGM on 12 May 2023 during the...
ESDR/MONTAGNA TRAVEL AWARD
ESDR will offer two (2) travel awards of EUR 2’000 each to support ESDR members aged 40 and...
About The ESDR
The European Society for Dermatological Research (ESDR), founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. The ESDR is the largest investigative dermatology society in Europe with a current membership of over 1200.
By supporting investigative dermatology, the ESDR contributes towards improving the health of patients suffering from skin and venereal disease. Applications of recent scientific advances have produced diagnostic and therapeutic innovations in dermatological practice, particularly in genetics, skin cancer, allergic skin disease, infectious disease and autoimmune diseases.


ABOUT JID
The Journal of Investigative Dermatology (JID) is the official journal of the ESDR and SID. JID publishes papers describing original research on all aspects of cutaneous biology and skin disease. Topics include biochemistry, biophysics, cell regulation, carcinogenesis, skin structure, extracellular matrix, genetics, immunology, melanocyte biology, microbiology, molecular and cell biology, pathology, physiology, pharmacology, photobiology, percutaneous absorption, clinical research, epidemiology and other population-based research.
JID Latest
- Keratinocytes of the Upper Epidermis and Isthmus of Hair Follicles Express Hemoglobin mRNA and Protein
- Highly efficient ex-vivo correction of COL7A1 through RNP-based CRISPR/Cas9 and Homology-Directed Repair to treat recessive dystrophic epidermolysis bullosa
- Editors’ Picks
- Clinical Snippets
- Subscription Information